Sero-prevalence of toxoplasmosis and Role of Cathepsin L-like and Cathepsin B-like Genes as Risk Factors for Abnormal Pregnancy Outcome

Authors

  • noor meran omer Hawler Medical University- College of Medicine
  • Hadi M. A. Alsakee 2 Department of Basic Science, College of Medicine, Hawler Medical University.

DOI:

https://doi.org/10.23851/mjs.v30i4.720

Keywords:

Toxoplasma gondii, Cathepsin L like, Cathepsin B like, PCR.

Abstract

Background and objectives: Toxoplasma gondii (T. gondii) is a ubiquitous apicomplexan parasite. As an obligate intracellular parasite, T. gondii must invade host cells to survive and replicate. Five cathepsin proteases are encoded in the genome of T. gondii, cathepsin L like protein, cathepsin B like protein, and three cathepsin C like proteins. The present study was aimed to investigate the prevalence of toxoplasmosis among women in Erbil, and to study the role of cathepsin B and cathepsin L genes in the pathogenesis of toxoplasmosis as well as their role as risk factors for abnormal pregnancy outcome. Methods: This is a cross sectional study was carried out in Erbil from October 2018 to March 2019.  A total of 230 women at their reproductive age and who attended Maternity Teaching Hospital and Nazdar Bamarni primary Health Center were enrolled. Anti- toxoplasma IgG and IgM antibodies were detected by cobas 6000. Toxoplasma cathepsin B and cathepsin L – like genes were selected to be targets in PCR. Results: Anti-toxoplasma IgG and IgM were seropositive in 105 (45.7%) and 18 (7.8%) women, respectively. Of those women who were seropositive for toxoplasmosis, only 15(6.5%) of them were carrying both anti-toxoplasma IgG and IgM. No significant association of toxoplasmosis and educational level, socioeconomic level, age, history of abortion, abnormal baby birth weight were observed. PCR targeting cathepsin L was more sensitive to be used in the diagnosis of toxoplasmosis. Conclusion: Sero-prevalence of toxoplasmosis is relatively high in Erbil and cathepsin L gene is an efficient target for PCR and could be used as risk factor for abnormal pregnancy outcome.

Downloads

Download data is not yet available.

References

Dubey JP. Toxoplasma Gondii. In: Baron S, editor. Medical Microbiology [Internet]. 4th ed. Galveston (TX): University of Texas Medical Branch at Galveston; 1996 [cited 2019 Apr 17]. [Online]

Montoya JG, Remington JS. Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis Off Publ Infect Dis Soc Am. 2008 Aug 15;47(4):554-66. [CrossRef] [PubMed]

Ezechi OC, David AN, Ogabido AC, Nwosu OB. Toxoplasma Gondii Infection in Pregnancy and Neonatal period. NJCBR Online. 2017 Jun 1;7(8):6-19. [CrossRef] [PubMed]

MEIRELES LR, EKMAN CCJ, de ANDRADE HF, LUNA EJ de A. HUMAN TOXOPLASMOSIS OUTBREAKS AND THE AGENT INFECTING FORM. FINDINGS FROM A SYSTEMATIC REVIEW. Rev Inst Med Trop São Paulo. 2015;57(5):369-76. [CrossRef] [PubMed]

Nimri L, Pelloux H, Elkhatib L. Detection of Toxoplasma gondii DNA and specific antibodies in high-risk pregnant women. Am J Trop Med Hyg. 2004 Dec;71(6):831-5. [CrossRef] [PubMed]

Singh S. Mother-to-child transmission and diagnosis of Toxoplasma gondii infection during pregnancy. Indian J Med Microbiol. 2003 Jun;21(2):69-76.

Liu Q, Wang Z-D, Huang S-Y, Zhu X-Q. Diagnosis of toxoplasmosis and typing of Toxoplasma gondii. Parasit Vectors. 2015 May 28;8(1):292. [CrossRef] [PubMed]

Grover CM, Thulliez P, Remington JS, Boothroyd JC. Rapid prenatal diagnosis of congenital Toxoplasma infection by using polymerase chain reaction and amniotic fluid. J Clin Microbiol. 1990 Oct;28(10):2297-301. [CrossRef] [PubMed]

Millar PR, de Moura FL, Bastos OMP, de Mattos DPBG, Fonseca ABM, Sudré AP, et al. TOXOPLASMOSIS-RELATED KNOWLEDGE AMONG PREGNANT AND POSTPARTUM WOMEN ATTENDED IN PUBLIC HEALTH UNITS IN NITERÓI, RIO DE JANEIRO, BRAZIL. Rev Inst Med Trop São Paulo. 2014; 56(5):433-8. [CrossRef] [PubMed]

Lopes-Mori FMR, Mitsuka-Breganó R, Capobiango JD, Inoue IT, Reiche EMV, Morimoto HK, et al. Programs for control of congenital toxoplasmosis. Rev Assoc Médica Bras. 2011 Oct;57(5):594-9. [CrossRef] [PubMed]

Jones CD, Okhravi N, Adamson P, Tasker S, Lightman S. Comparison of PCR detection methods for B1, P30, and 18S rDNA genes of T. gondii in aqueous humor. Invest Ophthalmol Vis Sci. 2000 Mar;41(3):634-44.

Burg JL, Grover CM, Pouletty P, Boothroyd JC. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J Clin Microbiol. 1989 Aug; 27(8):1787-92. [CrossRef] [PubMed]

Dou Z, Carruthers VB. CATHEPSIN PROTEASES IN TOXOPLASMA GONDII [Internet]. Landes Bioscience; 2013 [cited 2019 Aug 9]. [Online]

Teo CF, Zhou XW, Bogyo M, Carruthers VB. Cysteine protease inhibitors block Toxoplasma gondii microneme secretion and cell invasion. Antimicrob Agents Chemother. 2007 Feb;51(2):679-88. [CrossRef] [PubMed]

Larson ET, Parussini F, Huynh M-H, Giebel JD, Kelley AM, Zhang L, et al. Toxoplasma gondii cathepsin L is the primary target of the invasion-inhibitory compound morpholinurea-leucyl-homophenyl-vinyl sulfone phenyl. J Biol Chem. 2009 Sep 25;284(39):26839-50. [CrossRef] [PubMed]

Huang R, Que X, Hirata K, Brinen LS, Lee JH, Hansell E, et al. The cathepsin L of Toxoplasma gondii (TgCPL) and its endogenous macromolecular inhibitor, toxostatin. Mol Biochem Parasitol. 2009 Mar;164(1):86-94. [CrossRef] [PubMed]

Que X, Ngo H, Lawton J, Gray M, Liu Q, Engel J, et al. The cathepsin B of Toxoplasma gondii, toxopain-1, is critical for parasite invasion and rhoptry protein processing. J Biol Chem. 2002 Jul 12;277(28):25791-7. [CrossRef] [PubMed]

van Deutekom AW, Chinapaw MJM, Jansma EP, Vrijkotte TGM, Gemke RJBJ. The Association of Birth Weight and Infant Growth with Energy Balance-Related Behavior - A Systematic Review and Best-Evidence Synthesis of Human Studies. PLoS ONE [Internet]. 2017 Jan 12 [cited 2019 Aug 9];12(1). [CrossRef] [PubMed]

Lopes-Mori FMR, Mitsuka-Breganó R, Capobiango JD, Inoue IT, Reiche EMV, Morimoto HK, et al. Programs for control of congenital toxoplasmosis. Rev Assoc Médica Bras. 2011 Oct;57(5):594-9. [CrossRef] [PubMed]

Bakre HM. Serological tests and polymerase chain reaction for detection of Toxoplasma gondii infection in women attending for premarital examination. Zanco J Med Sci Zanco J Med Sci. 2016;20(3):1476_1484-1476_1484. [CrossRef]

Mostafaal-Atroshi AAA, Mero WMS. Seroprevalence of Anti - Toxoplasma Antibodies Among Women of Child Bearing Age in Duhok Province. Sci J Univ Zakho. 2013 Jun 30;1(1):44-9.

Ali SI. Epidemiological Survey of Toxoplasmosis among Aborted Women in Garmian district, Kurdistan Region, Iraq. Kurd J Appl Res. 2018 Jul 23;140-5. [CrossRef]

Salih HA. Prevalence of toxoplasmosis among pregnant women in Najaf city. 2010;8.

Rasti S, Hooshyar H, Arbabi M, Fatahian A, Behrashi M, Talebian A, et al. Frequency of Toxoplasma Infection Among Pregnant Women and Their Newborn in Kashan, Iran. Zahedan J Res Med Sci. 2015 May 11;17:E999. [CrossRef]

Alghamdi J, Elamin MH, Alhabib S. Prevalence and genotyping ofToxoplasma gondii among Saudi pregnant women in Saudi Arabia. Saudi Pharm J SPJ Off Publ Saudi Pharm Soc. 2016 Nov;24(6):645-51. [CrossRef] [PubMed]

Iddawela D, Vithana SMP, Ratnayake C. Seroprevalence of toxoplasmosis and risk factors of Toxoplasma gondii infection among pregnant women in Sri Lanka: a cross sectional study. BMC Public Health [Internet]. 2017 Dec 4 [cited 2019 Aug 9];17. [CrossRef] [PubMed]

Borkakoty B, Biswas D, Jakharia A, Mahanta J. Seroprevalence of Toxoplasma gondii Among Pregnant Women in Northeast India. J Assoc Physicians India. 2016;64(10):24-8.

Saki J, Mohammadpour N, Moramezi F, Khademvatan S. Seroprevalence of Toxoplasma gondii in Women Who Have Aborted in Comparison with the Women with Normal Delivery in Ahvaz, Southwest of Iran [Internet]. The Scientific World Journal. 2015 [cited 2019 Sep 7]. [CrossRef] [PubMed]

Singh S, Munawwar A, Rao S, Mehta S, Hazarika NK. Serologic Prevalence of Toxoplasma gondii in Indian Women of Child Bearing Age and Effects of Social and Environmental Factors. PLoS Negl Trop Dis [Internet]. 2014 Mar 27 [cited 2019 Aug 9];8(3). [CrossRef] [PubMed]

Mizani A, Alipour A, Sharif M, Sarvi S, Amouei A, Shokri A, et al. Toxoplasmosis seroprevalence in Iranian women and risk factors of the disease: a systematic review and meta-analysis. Trop Med Health. 2017 Apr 12;45(1):7. [CrossRef] [PubMed]

Khanal V, Sauer K, Karkee R, Zhao Y. Factors associated with small size at birth in Nepal: further analysis of Nepal Demographic and Health Survey 2011. BMC Pregnancy Childbirth. 2014 Jan 18;14:32. [CrossRef] [PubMed]

Gebregzabiherher Y, Haftu A, Weldemariam S, Gebrehiwet H. The Prevalence and Risk Factors for Low Birth Weight among Term Newborns in Adwa General Hospital, Northern Ethiopia. Obstet Gynecol Int. 2017;2017:2149156. 2017(1):1-7. [CrossRef] [PubMed]

Downloads

Key Dates

Published

15-01-2020

Issue

Section

Original Article

How to Cite

[1]
noor meran omer and H. M. A. Alsakee, “Sero-prevalence of toxoplasmosis and Role of Cathepsin L-like and Cathepsin B-like Genes as Risk Factors for Abnormal Pregnancy Outcome”, Al-Mustansiriyah Journal of Science, vol. 30, no. 4, pp. 43–50, Jan. 2020, doi: 10.23851/mjs.v30i4.720.

Similar Articles

1-10 of 17

You may also start an advanced similarity search for this article.